These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 3973390)

  • 1. Growth cycle-dependent generation of complement-resistant Leishmania promastigotes.
    Franke ED; McGreevy PB; Katz SP; Sacks DL
    J Immunol; 1985 Apr; 134(4):2713-8. PubMed ID: 3973390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.
    Sacks DL; Hieny S; Sher A
    J Immunol; 1985 Jul; 135(1):564-9. PubMed ID: 2582050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killing of Leishmania tropica amastigotes by factors in normal human serum.
    Hoover DL; Berger M; Nacy CA; Hockmeyer WT; Meltzer MS
    J Immunol; 1984 Feb; 132(2):893-7. PubMed ID: 6690622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages.
    Wozencraft AO; Blackwell JM
    Immunology; 1987 Apr; 60(4):559-63. PubMed ID: 2953670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metacyclogenesis of Leishmania spp: species-specific in vitro transformation, complement resistance, and cell surface carbohydrate and protein profiles.
    Bandyopadhyay P; Ghosh DK; De A; Ghosh KN; Chaudhuri PP; Das P; Bhattacharya A
    J Parasitol; 1991 Jun; 77(3):411-6. PubMed ID: 2040953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of lethal effect of human serum upon Leishmania donovani.
    Pearson RD; Steigbigel RT
    J Immunol; 1980 Nov; 125(5):2195-201. PubMed ID: 7430624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes.
    Felizardo TC; Toma LS; Borges NB; Lima GM; Abrahamsohn IA
    Parasitology; 2007 Nov; 134(Pt 12):1699-707. PubMed ID: 17655808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.
    Puentes SM; Da Silva RP; Sacks DL; Hammer CH; Joiner KA
    J Immunol; 1990 Dec; 145(12):4311-6. PubMed ID: 2147941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania amastigotes: resistance to complement-mediated lysis is not due to a failure to fix C3.
    Mosser DM; Wedgwood JF; Edelson PJ
    J Immunol; 1985 Jun; 134(6):4128-31. PubMed ID: 3886796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential survival of Leishmania donovani amastigotes in human monocytes.
    Pearson RD; Harcus JL; Roberts D; Donowitz GR
    J Immunol; 1983 Oct; 131(4):1994-9. PubMed ID: 6619546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania species: mechanisms of complement activation by five strains of promastigotes.
    Mosser DM; Burke SK; Coutavas EE; Wedgwood JF; Edelson PJ
    Exp Parasitol; 1986 Dec; 62(3):394-404. PubMed ID: 3780933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization in vivo and in vitro of a strain of Leishmania (Viannia) shawi from the Amazon Region.
    Ramos PK; Diniz JA; Silva EO; Quaresma JA; Saraiva EM; Seabra SH; Atella GC; de Souza W
    Parasitol Int; 2009 Jun; 58(2):154-60. PubMed ID: 19567230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania spp: temperature sensitivity of promastigotes in vitro as a model for tropism in vivo.
    Callahan HL; Portal IF; Bensinger SJ; Grogl M
    Exp Parasitol; 1996 Dec; 84(3):400-9. PubMed ID: 8948329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A spectrum in the susceptibility of leishmanial strains to intracellular killing by murine macrophages.
    Scott P; Sher A
    J Immunol; 1986 Feb; 136(4):1461-6. PubMed ID: 3511147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages.
    Da Silva RP; Hall BF; Joiner KA; Sacks DL
    J Immunol; 1989 Jul; 143(2):617-22. PubMed ID: 2525590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65,000-dalton surface antigen.
    Kweider M; Lemesre JL; Darcy F; Kusnierz JP; Capron A; Santoro F
    J Immunol; 1987 Jan; 138(1):299-305. PubMed ID: 3782801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Giardia lamblia trophozoites to the lethal effect of human serum.
    Hill DR; Burge JJ; Pearson RD
    J Immunol; 1984 Apr; 132(4):2046-52. PubMed ID: 6699407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative real-time kinetic analysis of human complement killing of Leishmania infantum promastigotes derived from axenic culture or from Phlebotomus perniciosus.
    Moreno I; Molina R; Toraño A; Laurin E; García E; Domínguez M
    Microbes Infect; 2007; 9(14-15):1574-80. PubMed ID: 18023393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani, L. major and L. mexicana.
    Zakai HA; Chance ML; Bates PA
    Parasitology; 1998 Apr; 116 ( Pt 4)():305-9. PubMed ID: 9585932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.